Literature DB >> 28199393

Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.

Kentaro Minagawa, Muhammad O Jamil, Mustafa Al-Obaidi, Larisa Pereboeva, Donna Salzman, Harry P Erba, Lawrence S Lamb, Ravi Bhatia, Shin Mineishi, Antonio Di Stasi.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0166891.].

Entities:  

Year:  2017        PMID： 28199393      PMCID： PMC5310889          DOI： 10.1371/journal.pone.0172640

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The following information is missing from the Funding section: A.D. was supported by an American Cancer Society (ACS) New faculty Career Development Grant, and by a “Walter B. Frommeyer Jr. Fellowship in investigative medicine."
  1 in total

1.  In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.

Authors:  Kentaro Minagawa; Muhammad O Jamil; Mustafa Al-Obaidi; Larisa Pereboeva; Donna Salzman; Harry P Erba; Lawrence S Lamb; Ravi Bhatia; Shin Mineishi; Antonio Di Stasi
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240
  1 in total
  2 in total

Review 1.  Immunotherapy in ovarian cancer.

Authors:  K Odunsi
Journal:  Ann Oncol       Date:  2017-11-01       Impact factor: 32.976

Review 2.  Chimeric antigen receptor T-cell therapy in acute myeloid leukemia.

Authors:  Jan Koedam; Martin Wermke; Armin Ehninger; Marc Cartellieri; Gerhard Ehninger
Journal:  Curr Opin Hematol       Date:  2022-03-01       Impact factor: 3.284
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.